VGX Animal Health, Inc. is a subsidiary of VGX™ Pharmaceuticals, Inc. and is focused on the development of pharmaceutical products for animal health applications.

VGX Animal Health was founded to bring cutting edge technologies to the world of animal health. Over the last decade, a group of dedicated researchers has developed a wide range of technologies that hold promise for enhancing the performance and welfare of the world's animal populations.

After treating thousands of animals with our GHRH therapy, we know that this technology has the potential to positively impact many animal species.

In the process of addressing some of the world's most significant health challenges, we are developing solid technological solutions in an effort to solve some of the animal health challenges.

Please explore our website to learn more about some of the innovative ways we are improving the well-being of animals, which in turn will enhance the lives of the people who care for them.
   

8/25/2008
VGX Pharmaceuticals announces the publication of pivotal data from its LifeTide™ SW 5 studies, which led to the approval in Australia of the GHRH gene therapy product for pigs
6/17/2008
VGX Gene Therapy Technology Featured at the 90th Annual Endocrine Society Meeting
5/22/2008
VGX Pharmaceuticals announces publication in Molecular Therapy regarding the Company’s GHRH gene therapy product
4/4/2008
Preliminary Study Performed on New Laminitis Treatment Technique


© 2008 VGX™ Animal Health. All rights reserved.